|
The Immunohistochemistry Antibody Company
|
|
|
Skin Cancer Screen 29 Tissue Microarray - LS-SSKCA29This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SSKCA29 |
| Product Name: | Skin Cancer Screen 29 |
| Description: | Skin basal cell cancer with normal/non-neoplastic skin |
| Format: | FFPE |
| Category: | Human Tumor and Normal |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | No |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 48 |
| Cores: | 48 |
| Slides Per Set: | 1 |
LS-SSKCA29 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Skin (Skn); Skin, Axilla (Skn); Skin, Cheek (Skn); Skin, Ear (Skn); Skin, Eyelid (Skn); Skin, Face (Skn); Skin, Head (Skn); Skin, Leg (Skn); Skin, Mandible (Skn); Skin, Neck (Skn); Skin, Nose (Skn); Skin, Scalp (Skn); Skin, Thigh (Skn); Skin, Wrist (Skn);
LS-SSKCA29 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type |
|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | F | 57 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant |
| 1 | A2 | Human | M | 60 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | A3 | Human | M | 63 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant |
| 1 | A4 | Human | M | 77 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | A5 | Human | M | 44 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant |
| 1 | A6 | Human | M | 71 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | A7 | Human | M | 38 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant |
| 1 | A8 | Human | M | 87 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | B1 | Human | F | 70 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | B2 | Human | M | 55 y | Skin, Scalp (Skn) | Basal cell carcinoma | Malignant |
| 1 | B3 | Human | M | 52 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant |
| 1 | B4 | Human | M | 55 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | B5 | Human | F | 76 y | Skin, Cheek (Skn) | Basal cell carcinoma | Malignant |
| 1 | B6 | Human | M | 40 y | Skin (Skn) | Basal cell carcinoma | Malignant |
| 1 | B7 | Human | M | 65 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant |
| 1 | B8 | Human | M | 55 y | Skin, Ear (Skn) | Basal cell carcinoma | Malignant |
| 1 | C1 | Human | F | 84 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant |
| 1 | C2 | Human | F | 63 y | Skin, Neck (Skn) | Basal cell carcinoma | Malignant |
| 1 | C3 | Human | M | 41 y | Skin, Scalp (Skn) | Basal cell carcinoma | Malignant |
| 1 | C4 | Human | M | 62 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | C5 | Human | F | 54 y | Skin, Scalp (Skn) | Basal cell carcinoma | Malignant |
| 1 | C6 | Human | F | 70 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant |
| 1 | C7 | Human | M | 54 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant |
| 1 | C8 | Human | M | 82 y | Skin, Axilla (Skn) | Basal cell carcinoma | Malignant |
| 1 | D1 | Human | M | 80 y | Skin, Leg (Skn) | Basal cell carcinoma | Malignant |
| 1 | D2 | Human | F | 84 y | Skin, Neck (Skn) | Basal cell carcinoma | Malignant |
| 1 | D3 | Human | M | 65 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | D4 | Human | M | 67 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | D5 | Human | M | 73 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant |
| 1 | D6 | Human | F | 82 y | Skin, Thigh (Skn) | Basal cell carcinoma | Malignant |
| 1 | D7 | Human | M | 77 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant |
| 1 | D8 | Human | F | 62 y | Skin, Scalp (Skn) | Basal cell carcinoma | Malignant |
| 1 | E1 | Human | F | 85 y | Skin, Face (Skn) | Basal cell carcinoma | Malignant |
| 1 | E2 | Human | M | 63 y | Skin, Mandible (Skn) | Basal cell carcinoma | Malignant |
| 1 | E3 | Human | M | 65 y | Skin, Ear (Skn) | Basal cell carcinoma | Malignant |
| 1 | E4 | Human | M | 63 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant |
| 1 | E5 | Human | F | 50 y | Skin, Ear (Skn) | Basal cell carcinoma | Malignant |
| 1 | E6 | Human | M | 36 y | Skin, Ear (Skn) | Basal cell carcinoma with chronic inflammation | Malignant |
| 1 | E7 | Human | M | 50 y | Skin, Nose (Skn) | Basal cell carcinoma | Malignant |
| 1 | E8 | Human | F | 73 y | Skin, Eyelid (Skn) | Basal cell carcinoma | Malignant |
| 1 | F1 | Human | M | 35 y | Skin (Skn) | Normal | Benign non-neoplastic |
| 1 | F2 | Human | M | 35 y | Skin (Skn) | Normal | Benign non-neoplastic |
| 1 | F3 | Human | F | 21 y | Skin (Skn) | Normal | Benign non-neoplastic |
| 1 | F4 | Human | M | 47 y | Skin, Wrist (Skn) | Normal | Benign non-neoplastic |
| 1 | F5 | Human | M | 50 y | Skin (Skn) | Normal | Benign non-neoplastic |
| 1 | F6 | Human | M | 25 y | Skin (Skn) | Normal | Benign non-neoplastic |
| 1 | F7 | Human | M | 22 y | Skin (Skn) | Normal | Benign non-neoplastic |
| 1 | F8 | Human | M | 40 y | Skin (Skn) | Normal | Benign non-neoplastic |